{"database": "openregs", "table": "dockets", "rows": [["FDA-2025-P-4154", "FDA", "Request that the FDA determine whether Chewtadzy (tadalafil) Chewable Tablets, 5 mg, 10 mg, and 20 mg, approved under New Drug Application (NDA) number 218527, held by B Better, LLC, has been voluntarily withdrawn for reasons of safety or effectiveness", "Nonrulemaking", "2026-04-22T20:47:39Z", "0b000064b8fd6762"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-P-4154"], "units": {}, "query_ms": 16.196629032492638, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}